Literature DB >> 8697639

Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria.

C Wenisch1, H Wenisch, B Parschalk, S Vanijanonta, H Burgmann, M Exner, K Zedwitz-Liebenstein, F Thalhammer, A Georgopoulos, W Graninger, S Looareesuwan.   

Abstract

Serum sCD14, tumour necrosis factor-alpha (TNF-alpha), IL-6, and endotoxin were analysed in 45 patients with complicated malaria, in 14 patients with Gram-negative septicaemia and in 24 healthy subjects by ELISA. Malaria patients with renal failure (n = 16) had higher levels than patients without renal failure (n = 29) (8116 + 1440 micrograms/l versus 9453 + 1017 micrograms/l; P < 0.05) and both had higher levels than patients with septicaemia (6155 + 1635 micrograms/l) and normal subjects (2776 + 747 micrograms/l). A significant correlation between sCD14 and IL-6 (r = 0.756) and TNF (r = 0.822) existed. However, no relation between sCD14 and serum endotoxin or indices of clinical disease severity (parasitaemia, fever, parasite or fever clearance time) was seen. Although the role of sCD14 in malaria remains to be determined, elevated levels may participate in the inflammatory response in complicated malaria.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8697639      PMCID: PMC2200468          DOI: 10.1046/j.1365-2249.1996.d01-723.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Increased levels of soluble CD14 in sera of periodontitis patients.

Authors:  J Hayashi; T Masaka; I Ishikawa
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  Soluble CD14 activates monocytic cells independently of lipopolysaccharide.

Authors:  R Landmann; S Link; S Sansano; Z Rajacic; W Zimmerli
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Evaluation of Prognostic Impact of Soluble CD14 in B-Chronic Lymphocytic Leukemia.

Authors:  Waiel Al-Kahiry; Homam Sharshira; Amal Ghanem; Maha El-Gammal; Irene Lewis Mikhael
Journal:  Indian J Hematol Blood Transfus       Date:  2016-11-16       Impact factor: 0.900

4.  Elevated endotoxin levels in non-alcoholic fatty liver disease.

Authors:  Alison L Harte; Nancy F da Silva; Steven J Creely; Kirsty C McGee; Thomas Billyard; Elham M Youssef-Elabd; Gyanendra Tripathi; Esmat Ashour; Mohga S Abdalla; Hayat M Sharada; Ashraf I Amin; Alastair D Burt; Sudhesh Kumar; Christopher P Day; Philip G McTernan
Journal:  J Inflamm (Lond)       Date:  2010-03-30       Impact factor: 4.981

5.  Recombinant soluble CD14 reduces severity of intramammary infection by Escherichia coli.

Authors:  Jai-Wei Lee; Max J Paape; Theodore H Elsasser; Xin Zhao
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

6.  Plasma levels of eight different mediators and their potential as biomarkers of various clinical malaria conditions in African children.

Authors:  Rachida Tahar; Catarina Albergaria; Neil Zeghidour; Vincent Foumane Ngane; Leonardo K Basco; Christian Roussilhon
Journal:  Malar J       Date:  2016-06-29       Impact factor: 2.979

7.  KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite.

Authors:  Minako Ikoma; Soren Gantt; Corey Casper; Yuko Ogata; Qing Zhang; Ryan Basom; Michael R Dyen; Timothy M Rose; Serge Barcy
Journal:  PLoS One       Date:  2018-02-09       Impact factor: 3.240

8.  Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice.

Authors:  Miranda S Oakley; Victoria Majam; Babita Mahajan; Noel Gerald; Vivek Anantharaman; Jerrold M Ward; Lawrence J Faucette; Thomas F McCutchan; Hong Zheng; Masaki Terabe; Jay A Berzofsky; L Aravind; Sanjai Kumar
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

9.  Affinity proteomics reveals elevated muscle proteins in plasma of children with cerebral malaria.

Authors:  Julie Bachmann; Florence Burté; Setia Pramana; Ianina Conte; Biobele J Brown; Adebola E Orimadegun; Wasiu A Ajetunmobi; Nathaniel K Afolabi; Francis Akinkunmi; Samuel Omokhodion; Felix O Akinbami; Wuraola A Shokunbi; Caroline Kampf; Yudi Pawitan; Mathias Uhlén; Olugbemiro Sodeinde; Jochen M Schwenk; Mats Wahlgren; Delmiro Fernandez-Reyes; Peter Nilsson
Journal:  PLoS Pathog       Date:  2014-04-17       Impact factor: 6.823

10.  Genetic Diversity of CD14 Promoter Gene Polymorphism (rs2569190) is Associated With Regulation of Malaria Parasitemia and Susceptibility to Plasmodium falciparum Infection.

Authors:  Olusola Ojurongbe; Roland I Funwei; Tara J Snyder; Najihah Aziz; Yi Li; Catherine O Falade; Bolaji N Thomas
Journal:  Infect Dis (Auckl)       Date:  2017-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.